Acarix AB (publ) (STO: ACARIX)
Sweden
· Delayed Price · Currency is SEK 0.330
+0.010 (3.13%)
Nov 19, 2024, 5:29 PM CET
Acarix AB Company Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow.
It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States.
The company was founded in 2009 and is headquartered in Malmö, Sweden.
Acarix AB (publ)
| Country | Sweden |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 14 |
| CEO | Aamir Mahmood |
Contact Details
Address: Regus MalmOe Malmö, 215 32 Sweden | |
| Website | acarix.com |
Stock Details
| Ticker Symbol | ACARIX |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009268717 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Aamir Mahmood | President and Chief Executive Officer |
| Dr. Claus Bo Vöge Christensen | Founder and Interim Head of Research & Development |
| Christian Lindholm | Chief Financial Officer and Executive Vice President |
| Jennifer Matson | Head of Medical Affairs |
| Carma Connely | Head of Market Access and Customer Excellence |
| Jeff Thomas | Head of US Sales |